Hematologic Abnormalities in the Small Animal Cancer Patient

Veterinary Clinics of North America - Small Animal Practice

Volumn 42, Issue 1, 2012, Pages 123-155

  Childress, Michael O ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

Anemia; Cancer; Coagulopathy; Hematology; Thrombocytopenia

Indexed keywords

ANTINEOPLASTIC AGENT; INTERLEUKIN 5; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; RECOMBINANT ERYTHROPOIETIN;

ADVERSE OUTCOME; ANEMIA; BASOPHILIA; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CYTOKINE PRODUCTION; CYTOPENIA; DIAGNOSTIC TEST; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG SAFETY; DYSPROTEINEMIA; EOSINOPHILIA; ERYTHROCYTOSIS; HEMATOLOGIC DISEASE; HUMAN; HYPERCOAGULABILITY; HYPOCOAGULABILITY; IRON THERAPY; LEUKOCYTOSIS; MALIGNANT NEOPLASTIC DISEASE; MONOCYTOSIS; NONHUMAN; NUTRITIONAL DEFICIENCY; PANCYTOPENIA; POLYCYTHEMIA VERA; REVIEW; SURVIVAL TIME; THROMBOCYTOPENIA; THROMBOCYTOSIS;

ANIMALS; BLOOD CELL COUNT; CAT DISEASES; CATS; DOG DISEASES; DOGS; NEOPLASMS; PROGNOSIS;

ANIMALIA;

EID: 84856249556     PISSN: 01955616     EISSN: 18781306     Source Type: Journal    
DOI: 10.1016/j.cvsm.2011.09.009     Document Type: Review

References (240)

1. Glaspy J. Disorders of blood cell production in clinical oncology. Abeloff's clinical oncology 2008, 677-692. Churchill Livingstone, Philadelphia. 4th edition. M.D. Abeloff, J.E. Armitage, J.E. Niederhuber (Eds.).
2. Kaufman R.M., Anderson K.C. Hematologic complications and blood bank support. Cancer medicine 2010, 1797-1812. PMPH-USA, Shelton (CT). 8th edition. W.K. Hong, R.C. Bast, W.N. Hait (Eds.).
3. Couto C.G. Hematologic abnormalities in small animal cancer patients. Part I. Red blood cell abnormalities. Compend Contin Educ Vet 1984, 6:1059-1068.
4. Couto C.G. Hematologic abnormalities in small animal cancer patients. Part II. White blood cell, platelet, and combined abnormalities. Compend Contin Educ Vet 1985, 7:21-30.
5. Rosenthal R. Chemotherapy-induced myelosuppression. Kirk's current veterinary therapy X 1989, 494-497. WB Saunders, Philadelphia. R.W. Kirk (Ed.).
6. Barger A.M., Grindem C.B. Hematologic abnormalities associated with cancer therapy. Schalm's veterinary hematology 2000, 676-681. Lippincott Williams & Wilkins, Baltimore. 5th edition. B.F. Feldman, J.G. Zinkl, M.C. Jain (Eds.).
7. Axiak S.M., Carreras J.K., Hahn K.A., et al. Hematologic changes associated with half-body irradiation in dogs with lymphoma. J Vet Intern Med 2006, 20:1398-1401.
8. Spivak J.L., Gascón P., Ludwig H. Anemia management in oncology and hematology. Oncologist 2009, 14(suppl 1):43-56.
9. Ludwig H., Van Belle S., Barrett-Lee P., et al. The European cancer anaemia survey (ECAS): a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in cancer patients. Eur J Cancer 2004, 40:2293-2306.
10. Birgegård G., Gascón P., Ludwig H. Evaluation of anemia in patients with multiple myeloma and lymphoma: findings of the European Cancer Anemia Survey. Eur J Haematol 2006, 77:378-386.
11. Tchekmedyian N.S. Anemia in cancer patients: Significance, epidemiology, and current therapy. Oncology (Williston Park) 2002, 16(Suppl 10):17-24.
12. Madewell B.R., Feldman B.F. Characterization of anemias associated with neoplasia in small animals. J Am Vet Med Assoc 1980, 176:419-425.
13. Prymak C., McKee L.J., Goldschmidt M.H., et al. Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985). J Am Vet Med Assoc 1988, 193:706-712.
14. Smith A.N. Hemangiosarcoma in dogs and cats. Vet Clin North Am Small Anim Pract 2003, 33:533-552.
15. Weinstein M.J., Carpenter J.L., Schunk C.J.M. Nonangiogenic and nonlymphomatous sarcomas of the canine spleen: 57 cases (1975-1987). J Am Vet Med Assoc 1989, 195:784-788.
16. Aronsohn M.G., Dubiel B., Roberts B., et al. Prognosis for acute nontraumatic hemoperitoneum in the dog: A retrospective analysis of 60 cases (2003-2006). J Am Anim Hosp Assoc 2009, 45:72-77.
17. Pintar J., Breitschwerdt E.B., Hardie E.M., et al. Acute nontraumatic hemoabdomen in the dog: A retrospective analysis of 39 cases (1987-2001). J Am Anim Hosp Assoc 2003, 39:518-522.
18. Whittemore J.C., Preston C.A., Kyles A.E., et al. Nontraumatic rupture of an adrenal gland tumor causing intra-abdominal hemorrhage or retroperitoneal hemorrhage in four dogs. J Am Vet Med Assoc 2001, 219:329-333.
19. Gilson S.D., Withrow S.J., Wheeler S.J., et al. Pheochromocytoma in 50 dogs. J Vet Intern Med 1994, 8:228-232.
20. Slensky K.A., Volk S.W., Schwarz T., et al. Acute severe hemorrhage secondary to arterial invasion in a dog with thyroid carcinoma. J Am Vet Med Assoc 2003, 223:649-653.
21. Harvey J.W., French T.W., Meyer D.J. Chronic iron deficiency anemia in dogs. J Am Anim Hosp Assoc 1982, 18:946-960.
22. Ishiguro T., Kadosawa T., Takagi S., et al. Relationship of disease progression and plasma histamine concentrations in 11 dogs with mast cell tumors. J Vet Intern Med 2003, 17:194-198.
23. Fox L.E., Rosenthal R.C., Twedt D.C., et al. Plasma histamine and gastrin concentrations in 17 dogs with mast cell tumors. J Vet Intern Med 1990, 4:242-246.
24. Simpson K.W., Dykes N.L. Diagnosis and treatment of gastrinoma. Semin Vet Med Surg (Small Anim) 1997, 12:274-281.
25. McCullough S. Immune-mediated hemolytic anemia: Understanding the nemesis. Vet Clin North Am Small Anim Pract 2003, 33:1295-1315.
26. Balch A., Mackin A. Canine immune-mediated hemolytic anemia: Pathophysiology, clinical signs, and diagnosis. Compend Contin Educ Vet 2007, 29:217-225.
27. Shelton G.H., Linenberger M.L. Hematological abnormalities associated with retroviral infections in the cat. Semin Vet Med Surg (Small Anim) 1995, 10:220-233.
28. Linenberger M.L., Abkowitz J.L. Haematological disorders associated with feline retroviral infections. Baillière's Clin Haematol 1995, 8:73-112.
29. Harrus S., Klement E., Aroch I., et al. Retrospective study of 46 cases of feline haemobartonellosis in Israel and their relationship with FeLV and FIV infections. Vet Rec 2002, 151:82-85.
30. Sykes J.E. Feline hemotropic mycoplasmas. Vet Clin North Am Small Anim Pract 2010, 40:1157-1170.
31. Martinez J. Microangiopathic hemolytic anemia. Williams hematology 2001, 623-626. McGraw-Hill, New York. 6th edition. E. Beutler, M.A. Lichtman, B.S. Coller (Eds.).
32. Fukumura D., Jain R. Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization. Microvasc Res 2007, 74:72-84.
33. Hammer A.S., Couto C.G., Swardson C., et al. Hemostatic abnormalities in dogs with hemangiosarcoma. J Vet Intern Med 1991, 5:11-14.
34. Caldin M., Carli E., Furlanello T., et al. A retrospective study of 60 cases of eccentrocytosis in the dog. Vet Clin Pathol 2005, 34:224-231.
35. Thrall M.A. Regenerative anemia. Veterinary hematology and clinical chemistry 2004, 95-119. Lippincott Williams & Wilkins, Philadelphia. M.A. Thrall, D.C. Baker, T.W. Campbell (Eds.).
36. Christopher M.M. Relationship of endogenous Heinz bodies to disease and anemia in cats: 120 cases (1978-1987). J Am Vet Med Assoc 1989, 194:1089-1095.
37. Pavri R.S., Gupta A.D., Baxi A.J., et al. Further evidence for oxidative damage to hemoglobin and red cell membrane in leukemia. Leuk Res 1983, 7:729-733.
38. Moore P.F., Affolter V.K., Vernau W. Canine hemophagocytic histiocytic sarcoma: A proliferative disorder of CD11d+ macrophages. Vet Pathol 2006, 43:632-645.
39. Moore P.F., Rosin A. Malignant histiocytosis of Bernese mountain dogs. Vet Pathol 1986, 23:1-10.
40. Dobson J., Villiers E., Roulois A., et al. Histiocytic sarcoma of the spleen in flat-coated retrievers with regenerative anaemia and hypoproteinaemia. Vet Rec 2006, 158:825-829.
41. Fry M.M., Vernau W., Pesavento P.A., et al. Hepatosplenic lymphoma in a dog. Vet Pathol 2003, 40:556-562.
42. Carter J.E., Tarigo J.L., Vernau W., et al. Erythrophagocytic low-grade extranodal T-cell lymphoma in a cat. Vet Clin Pathol 2008, 37:416-421.
43. Marks S.L., Moore P.F., Taylor D.W., et al. Nonsecretory multiple myeloma in a dog: Immunohistologic and ultrastructural observations. J Vet Intern Med 1995, 9:50-54.
44. Yearley J.H., Stanton C., Olivry T., et al. Phagocytic plasmacytoma in a dog. Vet Clin Pathol 2007, 36:293-296.
45. Ledieu D., Palazzi X., Marchal T., et al. Acute megakaryoblastic leukemia with erythrophagocytosis and thrombosis in a dog. Vet Clin Pathol 2005, 34:52-56.
46. Madewell B.R., Gunn C., Gribble D.H. Mast cell phagocytosis of red blood cells in a cat. Vet Pathol 1983, 20:638-640.
47. Madewell B.R., Munn R.J., Phillips L.P. Endocytosis of erythrocytes in vivo and particulate substances in vitro by feline neoplastic mast cells. Can J Vet Res 1987, 51:517-520.
48. Allan R., Halsey T.R., Thompson K.G. Splenic mast cell tumor and mastocytaemia in a cat: case study and literature review. N Z Vet J 2000, 48:117-121.
49. Leifer C.E., Matus R.E. Lymphoid leukemia in the dog. Vet Clin North Am Small Anim Pract 1985, 15:723-739.
50. Cotter S.M., Essex M. Animal model: Feline acute lymphoblastic leukemia and aplastic anemia. Am J Pathol 1977, 87:265-268.
51. Blue J.T., French T.W., Kranz J.S. Non-lymphoid hematopoietic neoplasia in cats: A retrospective study of 60 cases. Cornell Vet 1988, 78:21-42.
52. Madewell B.R. Hematological and bone marrow cytological abnormalities in 75 dogs with malignant lymphoma. J Am Anim Hosp Assoc 1986, 22:235-240.
53. MacEwen E.G., Hurvitz A.I. Diagnosis and management of monoclonal gammopathies. Vet Clin North Am Small Anim Pract 1977, 7:119-133.
54. Marconato L., Bettini G., Giacoboni C., et al. Clinicopathological features and outcome for dogs with mast cell tumors and bone marrow involvement. J Vet Intern Med 2008, 22:1001-1007.
55. Affolter V.K., Moore P.F. Localized and disseminated histiocytic sarcoma of dendritic cell origin in dogs. Vet Pathol 2002, 39:74-83.
56. Pickens E.H., Kim D.Y., Gaunt S., et al. Unique radiographic appearance of bone marrow metastasis of an insulin-secreting beta-cell carcinoma in a dog. J Vet Intern Med 2005, 19:350-354.
57. Smith D.A., Hill F.W.G. Metastatic malignant mesothelioma in a dog. J Comp Path 1989, 100:97-101.
58. Kelly W.R., Wilkinson G.T., Allen P.W. Canine angiosarcomas (lymphangiosarcoma): A case report. Vet Pathol 1981, 18:224-227.
59. Birgegård G., Aapro M.S., Bokemeyer C., et al. Cancer-related anemia: Pathogenesis, prevalence, and treatment. Oncology 2005, 68(Suppl 1):3-11.
60. Grotto H.Z.W. Anaemia of cancer: an overview of mechanisms involved in its pathogenesis. Med Oncol 2008, 25:12-21.
61. Kiselow M.A., Rassnick K.M., McDonough S.P., et al. Outcome of cats with low-grade lymphocytic lymphoma: 41 cases (1995-2005). J Am Vet Med Assoc 2008, 232:405-410.
62. 12) in cats with gastrointestinal disease. J Vet Intern Med 2001, 15:26-32.
63. Ruaux C.G., Steiner J.M., Williams D.A. Early biochemical and clinical responses to cobalamin supplementation in cats with signs of gastrointestinal disease and severe hypocobalaminemia. J Vet Intern Med 2005, 19:155-160.
64. Morgan R.V. Blood dyscrasias associated with testicular tumors in the dog. J Am Anim Hosp Assoc 1982, 18:970-975.
65. McCandlish I.A.P., Munro C.D., Breeze R.G., et al. Hormone producing ovarian tumours in the dog. Vet Rec 1979, 105:9-11.
66. Weiss G., Goodnough L.T. Anemia of chronic disease. N Engl J Med 2005, 352:1011-1023.
67. Staszewski H. Hematological paraneoplastic syndromes. Semin Oncol 1997, 24:329-333.
68. McCown J.L., Specht A.J. Iron homeostasis and disorders in dogs and cats: A review. J Am Anim Hosp Assoc 2011, 47:151-160.
69. Caro J.J., Salas M., Ward A., et al. Anemia as an independent prognostic factor for survival in patients with cancer: A systematic quantitative review. Cancer 2001, 91:2214-2221.
70. Snyder S.A., Dewhirst M.W., Hauck M.L. The role of hypoxia in canine cancer. Vet Comp Oncol 2008, 6:213-223.
71. Rizzo J.D., Brouwers M., Hurley P., et al. American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. J Clin Oncol 2010, 33:4996-5010.
72. Abbo A.H., Lucroy M.D. Assessment of anemia as an independent predictor of response to chemotherapy and survival in dogs with lymphoma: 96 cases (1993-2006). J Am Vet Med Assoc 2007, 231:1836-1842.
73. Miller A.G., Morley P.S., Rao S., et al. Anemia is associated with decreased survival time in dogs with lymphoma. J Vet Intern Med 2009, 23:116-122.
74. Haney S.M., Beaver L., Turrel J., et al. Survival analysis of 97 cats with nasal lymphoma: A multi-institutional retrospective study (1986-2006). J Vet Intern Med 2009, 23:287-294.
75. Mayer M.M., Treur P.L., LaRue S.M. Radiotherapy and surgery for feline soft tissue sarcoma. Vet Radiol Ultrasound 2009, 50:669-672.
76. Madewell B.R., Feldman B.F., O'Neill S. Coagulation abnormalities in dogs with neoplastic disease. Thromb Haemost 1980, 44:35-38.
77. Jordan H.L., Grindem C.B., Breitschwerdt E.B. Thrombocytopenia in cats: A retrospective study of 41 cases. J Vet Intern Med 1993, 7:261-265.
78. Grindem C.B., Breitschwerdt E.B., Corbett W.T., et al. Thrombocytopenia associated with neoplasia in dogs. J Vet Inter Med 1994, 8:400-405.
79. Chisholm-Chait A. Mechanisms of thrombocytopenia in dogs with cancer. Compend Contin Educ Vet 2000, 22:1006-1018.
80. Comazzi S., Gelain M.E., Bonfanti U., et al. Acute megakaryoblastic leukemia in dogs: A report of three cases and review of the literature. J Am Anim Hosp Assoc 2010, 46:327-335.
81. Helfand S.C. Platelets and neoplasia. Vet Clin North Am Small Anim Pract 1988, 18:131-156.
82. Jain N.C., Switzer J.W. Autoimmune thrombocytopenia in dogs and cats. Vet Clin North Am Small Anim Pract 1981, 11:421-434.
83. Dircks B.H., Schuberth H., Mischke R. Underlying diseases and clinicopathologic variables of thrombocytopenic dogs with and without platelet-bound antibodies detected by use of a flow cytometric assay: 83 cases (2004-2006). J Am Vet Med Assoc 2009, 235:960-966.
84. Helfand S.C., Couto C.G., Madewell B.R. Immune-mediated thrombocytopenia associated with solid tumors in dogs. J Am Anim Hosp Assoc 1985, 21:787-794.
85. Thomas J.S. Non-immune-mediated thrombocytopenia. Schalm's veterinary hematology 2010, 596-604. Blackwell Publishing, Philadelphia. 6th edition. D.J. Weiss, K.J. Wardrop (Eds.).
86. Caine G.J., Stonelake P.S., Lip G.Y.H., et al. The hypercoagulable state of malignancy: Pathogenesis and current debate. Neoplasia 2002, 4:465-473.
87. Thomason J.D., Calvert C.A., Greene C.E. DIC: Diagnosing and treating a complex disorder. Vet Med 2005, 100:670-678.
88. O'Donnell M.R., Slichter S.J., Weiden P.L., et al. Platelet and fibrinogen kinetics in canine tumors. Cancer Res 1981, 41:1379-1383.
89. Slichter S.J., Harker L.J. Hemostasis in malignancy. Ann NY Acad Sci 1974, 230:252-261.
90. Adam F., Villiers E., Watson S., et al. Clinical pathological and epidemiological assessment of morphologically and immunologically confirmed canine leukemia. Vet Comp Oncol 2009, 7:181-195.
91. Tasca S., Carli E., Caldin M., et al. Hematologic abnormalities and flow cytometric immunophenotyping results in dogs with hematopoietic neoplasia: 210 cases (2002-2006). Vet Clin Pathol 2009, 38:2-12.
92. Weiss D.J., Evanson O.A., Sykes J. A retrospective of canine pancytopenia. Vet Clin Pathol 1999, 28:38-88.
93. Bryan J.N., Henry C.J., Turnquist S.E., et al. Primary renal neoplasia of dogs. J Vet Intern Med 2006, 20:1155-1160.
94. Durno A.S., Webb J.A., Gauthier M.J., et al. Polycythemia and inappropriate erythropoietin concentrations in two dogs with renal T-cell lymphoma. J Am Anim Hosp Assoc 2011, 47:122-128.
95. Snead E.C. A case of bilateral renal lymphosarcoma with secondary polycythaemia and paraneoplastic syndromes of hypoglycaemia and uveitis in an English Springer Spaniel. Vet Comp Oncol 2005, 3:139-144.
96. Crow S.E., Allen D.P., Murphy C.J., et al. Concurrent renal adenocarcinoma and polycythemia in a dog. J Am Anim Hosp Assoc 1995, 31:29-33.
97. Peterson M.E., Zanjani E.D. Inappropriate erythropoietin production from a renal carcinoma in a dog with polycythemia. J Am Vet Med Assoc 1981, 179:995-996.
98. Nelson R.W., Hager D., Zanjani E.D. Renal lymphosarcoma with inappropriate erythropoietin production in a dog. J Am Vet Med Assoc 1983, 182:1396-1397.
99. Gorse M.J. Polycythemia associated with renal fibrosarcoma in a dog. J Am Vet Med Assoc 1988, 192:793-794.
100. Henry C.J., Turnquist S.E., Smith A., et al. Primary renal tumors in cats: 19 cases (1992-1998). J Feline Med Surg 1999, 1:165-170.
101. Klainbart S., Segev G., Loeb E., et al. Resolution of renal adenocarcinoma-induced secondary inappropriate polycythaemia after nephrectomy in two cats. J Feline Med Surg 2008, 10:264-268.
102. Cohen D. The canine transmissible venereal tumor: A unique result of tumor progression. Adv Cancer Res 1985, 43:75-112.
103. Couto C.G., Boudrieau R.J., Zanjani E.D. Tumor-associated erythrocytosis in a dog with nasal fibrosarcoma. J Vet Intern Med 1989, 3:183-185.
104. Sato K., Hikasa Y., Morita T., et al. Secondary erythrocytosis associated with high plasma erythropoietin concentrations in a dog with cecal leiomyosarcoma. J Am Vet Med Assoc 2002, 220:486-490.
105. McGrath C.J. Polycythemia vera in dogs. J Am Vet Med Assoc 1974, 164:1117-1122.
106. Peterson M.E., Randolph J.F. Diagnosis of canine primary polycythemia and management with hydroxyurea. J Am Vet Med Assoc 1982, 180:415-418.
107. Evans L.M., Caylor K.B. Polycythemia vera in a cat and management with hydroxyurea. J Am Anim Hosp Assoc 1995, 31:434-438.
108. Nitsche E.K. Erythrocytosis in dogs and cats: Diagnosis and management. Compend Contin Educ Vet 2004, 26:104-119.
109. Waters D.J., Prueter J.C. Secondary polycythemia associated with renal disease in the dog: Two case reports and review of literature. J Am Anim Hosp Assoc 1988, 24:109-114.
110. DeSancho M.T., Rand J.H. Coagulopathic complications of cancer patients. Cancer medicine 2010, 1813-1822. PMPH-USA, Shelton (CT). 8th edition. W.K. Hong, R.C. Bast, W.N. Hait (Eds.).
111. Hammer A.S. Thrombocytosis in dogs and cats: A retrospective study. Comp Haematol Intl 1991, 1:181-186.
112. Rizzo F., Tappin S.W., Tasker S. Thrombocytosis in cats: a retrospective study of 51 cases (2000-2005). J Feline Med Surg 2007, 9:319-325.
113. Hogan D.F., Dhaliwal R.S., Sisson D.D., et al. Paraneoplastic thrombocytosis-induced systemic thromboembolism in a cat. J Am Anim Hosp Assoc 1999, 35:483-486.
114. Stokol S. Essential thrombocythemia and reactive thrombocytosis. Schalm's veterinary hematology 2010, 605-611. Blackwell Publishing, Philadelphia. 6th edition. D.J. Weiss, K.J. Wardrop (Eds.).
115. Marchetti V., Benetti C., Citi S., et al. Paraneoplastic hypereosinophilia in a dog with intestinal T-cell lymphoma. Vet Clin Pathol 2005, 34:259-263.
116. Liptak J.M., Dernell W.S., Monnet E., et al. Massive hepatocellular carcinoma in dogs: 48 cases (1992-2002). J Am Vet Med Assoc 2004, 225:1225-1230.
117. Bass M.C., Schultze A.E. Essential thrombocythemia in a dog: Case report and literature review. J Am Anim Hosp Assoc 1998, 34:197-203.
118. Degen M.A., Feldman B.F., Turrel J.M., et al. Thrombocytosis associated with a myeloproliferative disorder in a dog. J Am Vet Med Assoc 1989, 194:1457-1459.
119. Harvey J.W. Myeloproliferative disorders in dogs and cats. Vet Clin North Am Small Anim Pract 1981, 11:349-381.
120. Mears E.A., Raskin R.E., Legendre A.M. Basophilic leukemia in a dog. J Vet Intern Med 1997, 11:92-94.
121. MacEwen E.G., Drazner F.H., McClelland A.J., et al. Treatment of basophilic leukemia in a dog. J Am Vet Med Assoc 1975, 166:376-380.
122. Dunn J.K., Heath M.F., Jefferies A.R., et al. Diagnostic and hematologic features of probable essential thrombocythemia in two dogs. Vet Clin Pathol 1999, 28:131-138.
123. Hopper P.E., Mandell C.P., Turrel J.M., et al. Probable essential thrombocythemia in a dog. J Vet Intern Med 1989, 3:79-85.
124. Mizukoshi T., Fujino Y., Yasukawa K., et al. Essential thrombocythemia in a dog. J Vet Med Sci 2006, 68:1203-1206.
125. Simpson J.W., Else R.W., Honeyman P. Successful treatment of suspected essential thrombocythaemia in the dog. J Small Anim Pract 1990, 31:345-348.
126. Hammer A.S., Couto C.G., Getzy D., et al. Essential thrombocythemia in a cat. J Vet Intern Med 1990, 4:87-91.
127. Thompson J.P., Christopher M.M., Ellison G.W., et al. Paraneoplastic leukocytosis associated with a rectal adenomatous polyp in a dog. J Am Vet Med Assoc 1992, 201:737-738.
128. Knottenbelt C.M., Simpson J.W., Chandler M.L. Neutrophilic leukocytosis in a dog with a rectal tumor. J Small Anim Pract 2000, 41:457-460.
129. Lappin M.R., Latimer K.S. Hematuria and extreme neutrophilic leukocytosis in a dog with renal tubular carcinoma. J Am Vet Med Assoc 1988, 192:1289-1292.
130. Peeters D., Clercx C., Thiry A., et al. Resolution of paraneoplastic leukocytosis and hypertrophic osteopathy after resection of a renal transitional cell carcinoma producing granulocyte-macrophage colony-stimulating factor in a young bull terrier. J Vet Intern Med 2001, 15:407-411.
131. Sharkey L.C., Rosol T.J., Gröne A., et al. Production of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor by carcinomas in a dog and a cat with paraneoplastic leukocytosis. J Vet Intern Med 1996, 10:405-408.
132. Chinn D.R., Myers R.K., Matthews J.A. Neutrophilic leukocytosis associated with metastatic fibrosarcoma in a dog. J Am Vet Med Assoc 1985, 186:806-809.
133. Dole R.S., MacPhail C.M., Lappin M.R. Paraneoplastic leukocytosis with mature neutrophilia in a cat with pulmonary squamous cell carcinoma. J Feline Med Surg 2004, 6:391-395.
134. Dotti G., Garattini E., Borleri G., et al. Leucocyte alkaline phosphatase identifies terminally differentiated normal neutrophils and its lack in chronic myelogenous leukemia is not dependent on p210 tyrosine kinase activity. Br J Haematol 1999, 105:163-172.
135. Schultze A.E. Interpretation of canine leukocyte responses. Schalm's veterinary hematology 2010, 321-334. Blackwell Publishing, Philadelphia. 6th edition. D.J. Weiss, K.J. Wardrop (Eds.).
136. Kaushansky K., O'Hara P.J., Berkner K., et al. Genomic cloning, characterization, and multilineage growth-promoting activity of human granulocyte-macrophage colony-stimulating factor. Proc Natl Acad Sci USA 1986, 83:3101-3105.
137. Lucroy M.D., Madewell B.R. Clinical outcome and associated diseases in dogs with leukocytosis and neutrophilia: 118 cases (1996-1998). J Am Vet Med Assoc 1999, 214:805-807.
138. Lucroy M.D., Madewell B.R. Clinical outcome and diseases associated with extreme neutrophilic leukocytosis in cats: 104 cases (1991-1999). J Am Vet Med Assoc 2001, 218:736-739.
139. Gabor L.J., Canfield P.J., Malik R. Haematological and biochemical findings in cats in Australia with lymphosarcoma. Aust Vet J 2000, 78:456-461.
140. Leifer C.E., Matus R.E. Chronic lymphocytic leukemia in the dog: 22 cases (1974-1984). J Am Vet Med Assoc 1986, 189:214-217.
141. Raskin R.E., Krehbiel J.D. Prevalence of leukemic blood and bone marrow in dogs with multicentric lymphoma. J Am Vet Med Assoc 1989, 194:1427-1429.
142. Avery A.C., Avery P.R. Determining the significance of persistent lymphocytosis. Vet Clin North Am Small Anim Pract 2007, 37:267-282.
143. Batlivala T.P., Bacon N.J., Avery A.C., et al. Paraneoplastic T cell lymphocytosis associated with thymoma in a dog. J Small Anim Pract 2010, 51:491-494.
144. Raskin R.E., Krehbiel J.D. Myelodysplastic changes in a cat with myelomonocytic leukemia. J Am Vet Med Assoc 1985, 187:171-174.
145. Shimoda T., Shiranaga N., Mashita T., et al. Chronic myelomonocytic leukemia in a cat. J Vet Med Sci 2000, 62:195-197.
146. Rossi G., Gelain M.E., Foroni S., et al. Extreme monocytosis in a dog with chronic monocytic leukemia. Vet Rec 2009, 165:54-56.
147. Endicott M.M., Charney S.C., McKnight J.A., et al. Clinicopathological findings and results of bone marrow aspiration in dogs with cutaneous mast cell tumors: 157 cases (1999-2002). Vet Comp Oncol 2007, 5:31-37.
148. O'Keefe D.A., Couto C.G., Burke-Schwartz C., et al. Systemic mastocytosis in 16 dogs. J Vet Intern Med 1987, 1:75-80.
149. Peaston A.E., Griffey S.M. Visceral mast cell tumor with eosinophilia and eosinophilic peritoneal and pleural effusions in a cat. Aust Vet J 1994, 71:215-217.
150. Bortnokski H.B., Rosenthal R.C. Gastrointestinal mast cell tumors and eosinophilia in two cats. J Am Anim Hosp Assoc 1992, 28:271-275.
151. Lapointe J.-M., Higgins R.J., Kortz G.D., et al. Intravascular malignant T-cell lymphoma (malignant angioendotheliomatosis) in a cat. Vet Pathol 1997, 34:247-250.
152. Barrs V.R., Beatty J.A., McCandlish I.A., et al. Hypereosinophilic paraneoplastic syndrome in a cat with intestinal T-cell lymphosarcoma. J Small Anim Pract 2002, 43:401-405.
153. Cave T.A., Gault E.A., Argyle D.J. Feline epitheliotrophic T-cell lymphoma with paraneoplastic eosinophilia-immunochemotherapy with vinblastine and recombinant interferon a2b. Vet Comp Oncol 2004, 2:91-97.
154. Tomiyasu H., Fujino Y., Ugai J., et al. Eosinophilic infiltration into splenic B-cell high-grade lymphoma in a dog. J Vet Med Sci 2010, 72:1367-1370.
155. London C.A. Mast cell tumors in the dog. Vet Clin North Am Small Anim Pract 2003, 33:473-489.
156. Couto C.G. Tumor-associated eosinophilia in a dog. J Am Vet Med Assoc 1984, 184:837.
157. Losco P.E. Local and peripheral eosinophilia in a dog with anaplastic mammary carcinoma. Vet Pathol 1986, 23:536-538.
158. Sellon R.K., Rottman J.B., Jordan H.L. Hypereosinophilia associated with transitional cell carcinoma in a cat. J Am Vet Med Assoc 1992, 201:591-593.
159. Gelain M.E., Antoniazzi E., Bertazzolo W., et al. Chronic eosinophilic leukemia in a cat: cytochemical and immunophenotypical features. Vet Clin Pathol 2006, 35:454-459.
160. Huibregtse B.A., Turner J.L. Hypereosinophilic syndrome and eosinophilic leukemia: A comparison of 22 hypereosinophilic cats. J Am Anim Hosp Assoc 1994, 30:591-599.
161. Ndikuwera J., Smith D.A., Obwolo M.J., et al. Chronic granulocytic leukaemia/eosinophilic leukaemia in a dog?. J Small Anim Pract 1992, 33:553-557.
162. Mahaffey E.A., Brown T.P., Duncan J.R., et al. Basophilic leukemia in a dog. J Comp Path 1987, 97:393-399.
163. Alroy J. Basophilic leukemia in a dog. Vet Pathol 1972, 9:90-95.
164. Henness A.M., Crow S.E. Treatment of feline myelogenous leukemia: four case reports. J Am Vet Med Assoc 1977, 171:263-266.
165. Rossi S., Gelain M.E., Comazzi S. Disseminated histiocytic sarcoma with peripheral blood involvement in a Bernese Mountain dog. Vet Clin Pathol 2009, 38:126-130.
166. Bookbinder P.F., Butt M.T., Harvey H.J. Determination of the number of mast cells in lymph node, bone marrow, and buffy coat cytologic specimens from dogs. J Am Vet Med Assoc 1992, 200:1648-1650.
167. McManus P.M. Frequency and severity of mastocytaemia in dogs with and without mast cell tumors: 120 cases (1995-1997). J Am Vet Med Assoc 1999, 215:355-357.
168. Stockham S.L., Basel D.L., Schmidt D.A. Mastocytemia in dogs with acute inflammatory diseases. Vet Clin Pathol 1986, 15:16-21.
169. Cayatte S.M., McManus P.M., Miller W.H., et al. Identification of mast cells in buffy coat preparations from dogs with inflammatory skin diseases. J Am Vet Med Assoc 1995, 206:325-326.
170. Stockham S.L., Scott M.A. Erythrocytes. Fundamentals of veterinary clinical pathology 2002, 85-154. Iowa State Press, Ames (IA). S.L. Stockham, M.A. Scott (Eds.).
171. Shull R.M. Inappropriate marrow release of hematopoietic precursors in three dogs. Vet Pathol 1981, 18:569-576.
172. Johnson K.A., Powers B.E., Withrow S.J., et al. Splenomegaly in dogs: Predictors of neoplasia and survival after splenectomy. J Vet Intern Med 1989, 3:160-166.
173. Kleine L.J., Zook B.C., Munson T.O. Primary cardiac hemangiosarcomas in dogs. J Am Vet Med Assoc 1970, 157:326-337.
174. Sharkey L.C., Modiano J.F. Bone marrow-derived sarcomas. Schalm's veterinary hematology 2010, 447-450. Blackwell Publishing, Philadelphia. 6th edition. D.J. Weiss, K.J. Wardrop (Eds.).
175. Lamerato-Kozicki A.R., Helm K.M., Jubala C.M., et al. Canine hemangiosarcoma originates from hematopoietic precursors with potential for endothelial differentiation. Exp Hematol 2006, 34:870-878.
176. Francis J.L., Biggerstaff J., Amirkhosravi A. Hemostasis and malignancy. Semin Thromb Hemost 1998, 24:93-109.
177. Kristensen A.T., Wiinberg B., Jessen L.R., et al. Evaluation of human recombinant tissue factor-activated thromboelastography in 49 dogs with neoplasia. J Vet Intern Med 2008, 22:140-147.
178. Sun N.C.J., McAfee W.M., Hum G.J., et al. Hemostatic abnormalities in malignancy, a prospective study of one hundred eight patients. Part I. Coagulation studies. Am J Clin Pathol 1979, 71:10-16.
179. Rickles F.R., Edwards R.L. Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 1983, 62:14-31.
180. Deitcher S.R. Diagnosis, treatment, and prevention of cancer-related venous thrombosis. Abeloff's clinical oncology 2008, 693-715. Churchill Livingstone, Philadelphia. 4th edition. M.D. Abeloff, J.E. Armitage, J.E. Niederhuber (Eds.).
181. O'Keefe D.A., Couto C.G. Coagulation abnormalities associated with neoplasia. Vet Clin N Am Small Anim Pract 1988, 18:157-168.
182. Slappendel R.J., de Maat C.E.M., Rijnberk A., et al. Spontaneous consumption coagulopathy in a dog with thyroid cancer. Thromb Diath Haemorrh 1970, 24:129-135.
183. Chinn D.R., Dodds W.J., Selcer B.A. Prekallikrein deficiency in a dog. J Am Vet Med Assoc 1986, 188:69-71.
184. Prasse K.W., Hoskins J.D., Glock R.D., et al. Factor V deficiency and thrombocytopenia in a dog with adenocarcinoma. J Am Vet Med Assoc 1972, 160:204-207.
185. Jones D.R.E., Gruffydd-Jones T.J., McCullagh K.G. Disseminated intravascular coagulation in a dog with thoracic neoplasia. J Small Anim Pract 1980, 21:303-309.
186. Hargis A.M., Feldman B.F. Evaluation of hemostatic defects secondary to vascular tumors in dogs: 11 cases (1983-1988). J Am Vet Med Assoc 1991, 198:891-894.
187. Ihle S.L., Baldwin C.J., Pifer S.M. Probable recurrent femoral artery thrombosis in a dog with intestinal lymphosarcoma. J Am Vet Med Assoc 1996, 280:240-242.
188. Hottendorf G.H., Nielsen S.W., Kenyon A.J. Canine mastocytoma: I. Blood coagulation time in dogs with mastocytoma. Pathol Vet 1965, 2:129-141.
189. Fox P.R., Petrie J.-P., Hohenhaus A.E. Peripheral vascular disease. Textbook of veterinary internal medicine 2005, 1145-1165. Elsevier Saunders, St Louis. 6th edition. S.J. Ettinger, E.C. Feldman (Eds.).
190. Somer T., Meiselman H.J. Disorders of blood viscosity. Ann Med 1993, 24:31-39.
191. Matus R.E., Leifer C.E., MacEwen E.G., et al. Prognostic factors for multiple myeloma in the dog. J Am Vet Med Assoc 1986, 188:1288-1292.
192. Yip G.Y.H., Chin B.S.P., Blann A.D. Cancer and the prothrombotic state. Lancet Oncol 2002, 3:27-34.
193. Van Winkle T.J., Bruce E. Thrombosis of the portal vein in eleven dogs. Vet Pathol 1993, 30:28-35.
194. Laurenson M.P., Hopper K., Herrera M.A., et al. Concurrent diseases and conditions in dogs with splenic vein thrombosis. J Vet Intern Med 2010, 24:1298-1304.
195. LaRue M.J., Murtaugh R.J. Pulmonary thromboembolism in dogs: 47 cases (1986-1987). J Am Vet Med Assoc 1990, 197:1368-1372.
196. Rickles F.R. Mechanisms of cancer-induced thrombosis. Pathophysiol Haemost Thromb 2006, 35:103-110.
197. Stockhaus C., Kohn B., Rudolph R., et al. Correlation of haemostatic abnormalities with tumor stage and characteristics in dogs with mammary carcinoma. J Small Anim Pract 1999, 40:326-331.
198. Thomas J.S., Rogers K.S. Platelet aggregation and adenosine triphosphate secretion in dogs with untreated multicentric lymphoma. J Vet Intern Med 1999, 13:319-322.
199. McNiel E.A., Ogilvie G.K., Fettman M.J., et al. Platelet hyperfunction in dogs with malignancies. J Vet Intern Med 1997, 11:178-182.
200. Kol A., Marks S.L., Skorupski K.A., et al. Serial thromboelastographic monitoring of dogs with multicentric lymphoma. Research Abstract Program of the 2010 ACVIM Forum 2010, 22. [abstract 36], Anaheim (CA).
201. Boccaccio C., Sabatino G., Medico E., et al. The MET oncogene drives a genetic programme linking cancer to haemostasis. Nature 2005, 434:396-400.
202. Amirkhosravi M., Francis J.L. Procoagulant effects of the MC28 fibrosarcoma cell line in vitro and in vivo. Br J Haematol 1993, 85:736-744.
203. Wiinberg B., Jensen A.L., Johansson P.I., et al. Thromboelastographic evaluation of hemostatic function in dogs with disseminated intravascular coagulation. J Vet Intern Med 2008, 22:357-365.
204. Feldman B.F., Madewell B.R., O'Neill S. Disseminated intravascular coagulation: Antithrombin, plasminogen, and coagulation abnormalities in 41 dogs. J Am Vet Med Assoc 1981, 179:151-154.
205. Maruyama H., Miura T., Sakai M., et al. The incidence of disseminated intravascular coagulation in dogs with malignant neoplasia. J Vet Med Sci 2004, 66:573-575.
206. Susaneck S.J., Allen T.A., Hoopes J., et al. Inflammatory mammary carcinoma in the dog. J Am Anim Hosp Assoc 1983, 19:971-976.
207. Marconato L., Romanelli G., Stefanello D., et al. Prognostic factors for dogs with mammary inflammatory carcinoma: 43 cases (2003-2008). J Am Vet Med Assoc 2009, 235:967-972.
208. Stockham S.L., Scott M.A. Proteins. Fundamentals of veterinary clinical pathology 2002, 251-276. Iowa State Press, Ames (IA). S.L. Stockham, M.A. Scott (Eds.).
209. Giraudel J.M., Pagès J.-P., Guelfi J.-F. Monoclonal gammopathies in the dog: A retrospective study of 18 cases (1986-1999) and literature review. J Am Anim Hosp Assoc 2002, 38:135-147.
210. De Caprariis D., Sasanelli M., Paradies P., et al. Monoclonal gammopathy associated with heartworm disease in a dog. J Am Anim Hosp Assoc 2009, 45:296-300.
211. Hoenig M., O'Brien J.A. A benign hypergammaglobulinemia mimicking plasma cell myeloma. J Am Anim Hosp Assoc 1988, 24:688-690.
212. Taylor S.S., Tappin S.W., Dodkin S.J., et al. Serum protein electrophoresis in 155 cats. J Feline Med Surg 2010, 12:643-653.
213. Boyle T.E., Holowaychuk M.K., Adams A.K., et al. Treatment of three cats with hyperviscosity syndrome and congestive heart failure using plasmapheresis. J Am Anim Hosp Assoc 2011, 47:50-55.
214. Mellor P.J., Haugland S., Smith K.C., et al. Histopathologic, immunohistochemical, and cytologic analysis of feline myeloma-related disorders: further evidence for primary extramedullary development in the cat. Vet Pathol 2008, 45:159-173.
215. Hanna F. Multiple myeloma in cats. J Feline Med Surg 2005, 7:275-287.
216. Paoloni M., Khanna C. Translation of new cancer treatments from pet dogs to humans. Nat Rev Cancer 2008, 8:147-156.
217. Simon D., Nolte I., Eberle N., et al. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol. J Vet Intern Med 2006, 20:948-954.
218. Lucroy M.D., Christopher M.M., Kraegel S.A., et al. Anemia associated with canine lymphoma. Comp Hematol Int 1998, 8:1-6.
219. Zemann B.I., Moore A.S., Rand W.M., et al. A combination chemotherapy protocol (VELCAP-L) for dogs with lymphoma. J Vet Intern Med 1998, 12:465-470.
220. Moore A.S., Cotter S.M., Rand W.M., et al. Evaluation of a discontinuous treatment protocol (VELCAP-S) for canine lymphoma. J Vet Intern Med 2001, 15:348-354.
221. Mooney S.C., Hayes A.A., Matus R.E., et al. Renal lymphoma in cats: 28 cases (1977-1984). J Am Vet Med Assoc 1987, 191:1473-1477.
222. Krick E.L., Little L., Patel R., et al. Description of clinical and pathological findings, treatment and outcome of feline large granular lymphocyte lymphoma (1996-2004). Vet Comp Oncol 2008, 6:102-110.
223. Spodnick G.J., Berg J., Moore F.M., et al. Spinal lymphoma in cats: 21 cases (1976-1989). J Am Vet Med Assoc 1992, 200:373-376.
224. Mahoney O.M., Moore A.S., Cotter S.M., et al. Alimentary lymphoma in cats: 28 cases (1988-1993). J Am Vet Med Assoc 1995, 207:1593-1598.
225. Matus R.E., Leifer C.E., MacEwen E.G. Acute lymphoblastic leukemia in the dog: A review of 30 cases. J Am Vet Med Assoc 1983, 183:859-862.
226. Patel R.T., Caceres A., French A.F., et al. Multiple myeloma in cats: a retrospective study. Vet Clin Pathol 2005, 34:341-352.
227. Skorupski K.A., Clifford C.A., Paoloni M.C., et al. CCNU for the treatment of dogs with histiocytic sarcoma. J Vet Intern Med 2007, 21:121-126.
228. Fidel J., Schiller I., Hauser B., et al. Histiocytic sarcomas in flat-coated retrievers: a summary of 37 cases (November 1998-March 2005). Vet Comp Oncol 2006, 4:63-74.
229. Skorupski K.A., Rodriguez C.O., Krick E.L., et al. Long-term survival in dogs with localized histiocytic sarcoma treated with CCNU as adjuvant to local therapy. Vet Comp Oncol 2009, 7:139-144.
230. Abadie J., Hedan B., Cadieu E., et al. Epidemiology, pathology, and genetics of histiocytic sarcoma in the Bernese Mountain dog breed. J Hered 2009, 100(suppl 1):S19-S27.
231. Schultz R.M., Puchalski S.M., Kent M., et al. Skeletal lesions of histiocytic sarcoma in nineteen dogs. Vet Radiol Ultrasound 2007, 48:539-543.
232. Gieger T.L., Théon A.P., Werner J.A., et al. Biologic behavior and prognostic factors for mast cell tumors of the canine muzzle: 24 cases (1990-2001). J Vet Intern Med 2003, 17:687-692.
233. Takahashi T., Kadosawa T., Nagase M., et al. Visceral mast cell tumors in dogs: 10 cases (1982-1997). J Am Vet Med Assoc 2000, 216:222-226.
234. Kim S.E., Liptak J.M., Gall T.T., et al. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004). J Am Vet Med Assoc 2007, 231:1550-1557.
235. Wood C.A., Moore A.S., Gliatto J.M., et al. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993). J Am Anim Hosp Assoc 1998, 34:417-421.
236. Locke J.E., Barber L.G. Comparative aspects and clinical outcomes of canine renal hemangiosarcoma. J Vet Intern Med 2006, 20:962-967.
237. Shiu K.-B., Flory A.B., Anderson C.L., et al. Predictors of outcome in dogs with subcutaneous or intramuscular hemangiosarcoma. J Am Vet Med Assoc 2011, 238:472-479.
238. Culp W.T.N., Drobatz K.J., Glassman M.M., et al. Feline visceral hemangiosarcoma. J Vet Intern Med 2008, 22:148-152.
239. Kraje A.C., Mears E.A., Hahn K.A., et al. Unusual metastatic behavior and clinicopathologic findings in eight cats with cutaneous or visceral hemangiosarcoma. J Am Vet Med Assoc 1999, 214:670-672.
240. Scavelli T.D., Patnaik A.K., Mehlhaff C.J., et al. Hemangiosarcoma in the cat: Retrospective evaluation of 31 surgical cases. J Am Vet Med Assoc 1985, 187:817-819.